Journal Club: A Review of Topical and Intralesional Therapeutics for Different Types of Alopecia
July 2022
in “
European Journal of Dermatology
”
Studysummary This study found that using a method based on absolute PASI, patients with psoriasis receiving brodalumab had a higher probability of achieving and maintaining a treatment response over 52 weeks compared to those receiving ustekinumab.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on stm.cairn.info →